Fig. 2.
Long-term prognosis of cardiac troponin I elevation in patients with ACI. (1) Group 1 (cTnI < 0.03 μg/L); (2) group 2 (cTnI: 0.03–0.10 μg/L); and (3) group 3 (cTnI > 0.1 μg/L). The accumulated survival of thrombolysis-treated ACI patients stratified according to normal, low, and highly elevated cTnI levels. Kaplan–Meier curve (adjusted for ischemic stroke, atrial fibrillation, congestive heart failure, and mRS score at 3 months). Abbreviations: ACI, acute cerebral infarction; cTnI, cardiac troponin I; mRS, modified Rankin Scale